<DOC>
	<DOCNO>NCT02595853</DOCNO>
	<brief_summary>Hemospray™ new endoscopic hemostatic powder . Aims multicenter prospective study determine effectiveness Hemospray™ short medium term different clinical situation , predictive factor rebleeding Hemospray™ application , feasibility application hemostatic powder routine clinical practice study large sample patient .</brief_summary>
	<brief_title>Efficacy Novel Hemostatic Powder GI Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Male female age 18 need use Hemospray® care emergency . Upper gastrointestinal hemorrhage . Patients received information note study agree participate ( nonoral opposition gather patient 's medical record ) Non Patient guardianship , curatorship . Pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Upper GastroIntestinal bleeding , endoscopy , Hemospray</keyword>
</DOC>